Rod Blourtchi, PA-C

Rod Blourtchi practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Rod Blourtchi's NPI, 1902317423, was assigned on October 24, 2017. Rod Blourtchi holds California license PA54850.

Rod Blourtchi's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Rod Blourtchi's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Rod Blourtchi is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Rod Blourtchi to 1 more hospital, 4 medical groups and 2 group practices and clinics, each named with a free account. Rod Blourtchi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Rod Blourtchi practices, 5 sites in all. Vendor and product names are available with a free account.

Physician assistant is Rod Blourtchi's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Rod Blourtchi is licensed in California.

Dmand AI lists acute skin infection, arthritis, broken or dislocated ankle/ or foot, bursitis, carpal tunnel syndrome, chest wall injury, enthesopathy in arms and fibromyalgia and chronic pain among the conditions Rod Blourtchi treats.

CMS data shows 93 Medicare services from Rod Blourtchi across 5 procedure codes in 2024, for 83 Medicare patients. Medicare paid $4,730 for them. Every service was in an office.

CMS counts 83 Medicare patients who saw Rod Blourtchi in 2024. The largest group is 65 to 74, with 36 patients. 75% of them have arthritis, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.17, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Rod Blourtchi's median patient age at 69, with 59% women.

In 2024, Rod Blourtchi wrote 281 Medicare Part D claims for 147 patients. 93% of them were for generic drugs. CMS names the drug for 231 of them, across 8 drugs with 11 or more claims each, at $4,704 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Rod Blourtchi for performance year 2024, reported as part of a group. Rod Blourtchi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rod Blourtchi as offering telehealth.

CMS Open Payments shows 11 general payments to Rod Blourtchi from 4 drug and device companies in 2025. Food and beverage make up the largest share, 51% of the total. Zimmer Biomet Holdings, Inc. paid the most, $863.